AU2898300A - Modulators of fgl2 prothrombinase - Google Patents

Modulators of fgl2 prothrombinase

Info

Publication number: AU2898300A
Authority: AU; Australia
Prior art keywords: modulators; fgl2 prothrombinase; fgl2; prothrombinase
Prior art date: 1999-02-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU28983/00A

Inventor

Gary Levy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-26

Filing date

2000-02-25

Publication date

2000-09-21

2000-02-25 Application filed by Individual filed Critical Individual

2000-09-21 Publication of AU2898300A publication Critical patent/AU2898300A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU28983/00A 1999-02-26 2000-02-25 Modulators of fgl2 prothrombinase Abandoned AU2898300A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US12210999P	1999-02-26	1999-02-26
US60122109		1999-02-26
PCT/CA2000/000191 WO2000051636A1 (en)	1999-02-26	2000-02-25	Modulators of fgl2 prothrombinase

Publications (1)

Publication Number	Publication Date
AU2898300A true AU2898300A (en)	2000-09-21

Family

ID=22400667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU28983/00A Abandoned AU2898300A (en)	1999-02-26	2000-02-25	Modulators of fgl2 prothrombinase

Country Status (3)

Country	Link
AU (1)	AU2898300A (en)
CA (1)	CA2362566A1 (en)
WO (1)	WO2000051636A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060078550A1 (en) *	2002-02-07	2006-04-13	Gary Levy	Porcine fgl2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5604115A (en) *	1990-12-21	1997-02-18	The Rockefeller University	Liver enriched transcription factor

2000
- 2000-02-25 AU AU28983/00A patent/AU2898300A/en not_active Abandoned
- 2000-02-25 WO PCT/CA2000/000191 patent/WO2000051636A1/en not_active Ceased
- 2000-02-25 CA CA002362566A patent/CA2362566A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2362566A1 (en)	2000-09-08
WO2000051636A1 (en)	2000-09-08

Publication	Publication Date	Title
AU5259100A (en)	2000-11-10	Medicament
AU3692700A (en)	2000-08-07	High speed electro-optic modulator
AU2001271434A1 (en)	2003-01-08	Novel skateboard-bicycle combination
AU1173201A (en)	2001-05-14	Skin-gripper
AU2919001A (en)	2001-05-08	Syringe
AU4318000A (en)	2000-12-05	Agarobiose-containing composition
AU2678800A (en)	2000-09-04	Modified calycins
AU4340900A (en)	2001-01-22	Devices
AU5547000A (en)	2001-01-02	Novel treatment
AU1290501A (en)	2001-06-04	Composition
AU1887401A (en)	2001-06-25	Medicinal composition
AU6062700A (en)	2001-01-22	Devices
AU2023701A (en)	2001-06-18	Sketcher
AU1541601A (en)	2001-06-12	Syringes
AU4556800A (en)	2000-11-10	Novel treatment
AU1533601A (en)	2001-06-04	Hollow-needle devices
AU4568900A (en)	2000-12-12	Improved can
AU2359301A (en)	2001-06-04	Novel ss-defensins
AU6310600A (en)	2001-02-05	Composition
AU6062600A (en)	2001-01-22	Devices
AU7711800A (en)	2001-04-24	Novel uses of 2-bromopalmitate
AU6711500A (en)	2001-03-19	Dressing
AU1901801A (en)	2001-05-30	Glucofuranoses
AU2898300A (en)	2000-09-21	Modulators of fgl2 prothrombinase
AU3133400A (en)	2000-09-14	Syringe

Legal Events

Date	Code	Title	Description
2002-01-17	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase